CSL Limited (CSLLY)
(Delayed Data from OTC)
$86.56 USD
-0.15 (-0.17%)
Updated Aug 5, 2025 03:59 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CSLLY 86.56 -0.15(-0.17%)
Will CSLLY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CSLLY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CSLLY
ALKS or CSLLY: Which Is the Better Value Stock Right Now?
KMDA vs. CSLLY: Which Stock Should Value Investors Buy Now?
CSLLY: What are Zacks experts saying now?
Zacks Private Portfolio Services
BMRN vs. CSLLY: Which Stock Is the Better Value Option?
BMRN vs. CSLLY: Which Stock Should Value Investors Buy Now?
BMRN or CSLLY: Which Is the Better Value Stock Right Now?
Other News for CSLLY
U.S. to phase out funding for mRNA vaccine development
RFK Jr. formally orders removal of thimerosal from all flu vaccines
CSL Ltd Reorganizes R&D, Plans Workforce Reduction
CSL will reduce its R&D department, increase external alliances: Reuters
Why Vertex Pharmaceuticals Continues To Outperfrom